Joana Vidigal
@vidigaljoana.bsky.social
960 followers 240 following 43 posts
Studying small RNAs and Argonaute proteins in mammals using mouse genetics. Part time runner, full time mom of Best Kiddo Ever (BKE) https://ccr.cancer.gov/staff-directory/joana-a-vidigal
Posts Media Videos Starter Packs
Reposted by Joana Vidigal
pedroprocha.bsky.social
🚨🚨🚨 Please repost
We are looking for postdocs to join our lab at NIH.
Apply:
www.nichd.nih.gov/research/atNICHD/Investigators/rocha/apply
Learn more about training at NIH :
www.training.nih.gov/research-tra...
Job add showing the lab logo and the following text: 
WHAT WE OFFER
Fully-funded fellowships up to five years  Opportunity to start your own research program or lead ongoing projects.
Large, diverse and extraordinary scientific network at the NIH/Bethesda campus. 

Working at NIH offers the possibility of living in a diverse, liberal and vibrant city: Washington DC
Or in a calm residential area with great schools and good affordable housing: Bethesda and Rockville.
 
WHO YOU ARE
You share our enthusiasm for epigenetics, gene regulation, nuclear organization and mouse development. You have PhD-experience in one or more of the following: mouse development, mouse genetics, epigenetics, or computational biology.
Reposted by Joana Vidigal
slwolin.bsky.social
A giant thank you to @drjz.bsky.social and @vidigaljoana.bsky.social! It takes a village to celebrate #RNAday
drjz.bsky.social
NIH had fun celebrating another #RNAday. Thanks to @vidigaljoana.bsky.social for organizing this great event and @slwolin.bsky.social for building a strong RNA community.
Reposted by Joana Vidigal
drjz.bsky.social
NIH had fun celebrating another #RNAday. Thanks to @vidigaljoana.bsky.social for organizing this great event and @slwolin.bsky.social for building a strong RNA community.
Reposted by Joana Vidigal
jxhoffman.bsky.social
Unpause! I'm super happy to now be able to share the published version of our paper at Science Advances showing that:
1) active histone mods occur independently of transcription
2) transcription coordinates histone deacetylation at active promoters
www.science.org/doi/10.1126/...
RNA polymerase II coordinates histone deacetylation at active promoters
Transcription initiation limits histone acetylation and H2AZ incorporation at promoters.
www.science.org
Reposted by Joana Vidigal
ktr-nakanishi.bsky.social
My research group seeks a highly motivated Post-Bacc (or Tech). This position offers a unique opportunity to contribute to research on cleavage-inducing tiny RNAs (cityRNAs) to treat neurological and neuromuscular disorders, Cancer, Alzheimer's diseases, etc.
u.osu.edu/cbcundergrad...
Job Opportunity for Recent Graduates (Post-Bacc) | CBC Undergraduate Program
u.osu.edu
vidigaljoana.bsky.social
Together, our data show that Rtl1 is an essential mRNA cleavage target of AGO2 and suggest that the repurposing of a retrotransposon-Argonaute regulatory interaction contributed to the retention of AGO catalytic competence in mammals
vidigaljoana.bsky.social
And finally, if we restore silencing of Rtl1 in mutant endothelial cells, we can essentially rescue all the endothelial phenotypes we documented!
vidigaljoana.bsky.social
It is also an imprinted gene, expressed only from the paternal allele. The maternal allele expresses instead a cluster of miRNAs that overlap Rtl1 in an antisense manner.

And you guessed it: we can find Rtl1 cleavage products for these miRNAs in RNA from wild-type but not catalytic mutant animals
vidigaljoana.bsky.social
Who is Rtl1? It turns out it is a domesticated retrotransposon known to regulate endothelial cell function - these are the cells that line our vessels
vidigaljoana.bsky.social
Turns out that one of the up-regulated genes, Rtl1, has 10 (!!!) perfect binding sites for well-expressed miRNAs! 😱

This extent of complementarity is well known to trigger RNA cleavage by AGO2
vidigaljoana.bsky.social
This is also pretty obvious in expression profiles from these animals, which show numerous genes up-regulated, which are largely involved vasculature development
a volcano plot on the left shows genes dysregulated in Ago2 mutants, plot on the right shows enrichment of GO terms
vidigaljoana.bsky.social
It turns out, there a lot more wrong with these animals than just anemia (check out the paper for all the things we found!)

For one thing, these animals have extensive vascular defects characterized by enlarged and leaky vessels
immunofluorescence to CD31 endothelial cell marker shows enlarged fetal vessels in catalytic mutant animals, which is quantified on the right
vidigaljoana.bsky.social
So clearly there are other important cleavage targets in mammals.

We set out to find who they were!
vidigaljoana.bsky.social
These are so far the only cleavage targets in mammals whose dysregulation was shown to cause phenotypes in AGO2 catalytic dead mice - a very strong anemia

And yet.... these animals also die a few hours after birth! For unknown reasons!
vidigaljoana.bsky.social
It is fair to say that we have been obsessed with mammalian Argonaute proteins in the lab, and particularly the ability of AGO2 to slice transcripts!

This activity is incredibly conserved, and yet we have a poor understanding of what it's regulatory functions are in mammals 🤔
vidigaljoana.bsky.social
Our final speaker of the day is Astrid Haase, who will tell us about RNA-guided genome protection
vidigaljoana.bsky.social
Next speaker is Katie McJunkin who will tell us about the developmentally timed decay of an essential miRNA family